Report Overview
Report Overview
The Absorbable Drug-Eluting Coronary Stent System is an innovative medical device designed to treat coronary artery disease, especially for the recanalization of narrowed or blocked blood vessels. Unlike traditional metal drug-eluting stents, BVS can be gradually absorbed by the human body after completing its supporting function, restoring the natural state and elasticity of the blood vessels. This stent is made of biocompatible materials such as polylactic acid, and releases anti-proliferative drugs within a few months after implantation to prevent restenosis of the blood vessels.
The global Absorbable Drug Eluting Coronary Stent System market size was estimated at USD 5847.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Absorbable Drug Eluting Coronary Stent System market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Absorbable Drug Eluting Coronary Stent System market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Absorbable Drug Eluting Coronary Stent System market.
Global Absorbable Drug Eluting Coronary Stent System Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boston Scientific
Medtronic
Abbott
B.Braun
BD
Biotronik AG
Stentys SA
Sino Medical
Beijing ESSEN Technology
Beijing Advanced Medical Technologies
LifeTech Scientific Corporation
MicroPort Scientific Corporation
Yilson Medical Technology
Lepu Medical Technology
Shandong Huaan Biotechnology
Market Segmentation (by Type)
Rapamycin Eluting Stent
Everolimus Eluting Stent
Others
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Absorbable Drug Eluting Coronary Stent System Market
Overview of the regional outlook of the Absorbable Drug Eluting Coronary Stent System Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Absorbable Drug Eluting Coronary Stent System Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Absorbable Drug Eluting Coronary Stent System, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Absorbable Drug Eluting Coronary Stent System
- 1.2 Key Market Segments
- 1.2.1 Absorbable Drug Eluting Coronary Stent System Segment by Type
- 1.2.2 Absorbable Drug Eluting Coronary Stent System Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Absorbable Drug Eluting Coronary Stent System Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Absorbable Drug Eluting Coronary Stent System Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Absorbable Drug Eluting Coronary Stent System Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Absorbable Drug Eluting Coronary Stent System Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Absorbable Drug Eluting Coronary Stent System Product Life Cycle
- 3.3 Global Absorbable Drug Eluting Coronary Stent System Sales by Manufacturers (2020-2025)
- 3.4 Global Absorbable Drug Eluting Coronary Stent System Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Absorbable Drug Eluting Coronary Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Absorbable Drug Eluting Coronary Stent System Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Absorbable Drug Eluting Coronary Stent System Market Competitive Situation and Trends
- 3.8.1 Absorbable Drug Eluting Coronary Stent System Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Absorbable Drug Eluting Coronary Stent System Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Absorbable Drug Eluting Coronary Stent System Industry Chain Analysis
- 4.1 Absorbable Drug Eluting Coronary Stent System Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Absorbable Drug Eluting Coronary Stent System Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Absorbable Drug Eluting Coronary Stent System Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Absorbable Drug Eluting Coronary Stent System Market
- 5.7 ESG Ratings of Leading Companies
- 6 Absorbable Drug Eluting Coronary Stent System Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Absorbable Drug Eluting Coronary Stent System Sales Market Share by Type (2020-2025)
- 6.3 Global Absorbable Drug Eluting Coronary Stent System Market Size by Type (2020-2025)
- 6.4 Global Absorbable Drug Eluting Coronary Stent System Price by Type (2020-2025)
- 7 Absorbable Drug Eluting Coronary Stent System Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Absorbable Drug Eluting Coronary Stent System Market Sales by Application (2020-2025)
- 7.3 Global Absorbable Drug Eluting Coronary Stent System Market Size (M USD) by Application (2020-2025)
- 7.4 Global Absorbable Drug Eluting Coronary Stent System Sales Growth Rate by Application (2020-2025)
- 8 Absorbable Drug Eluting Coronary Stent System Market Sales by Region
- 8.1 Global Absorbable Drug Eluting Coronary Stent System Sales by Region
- 8.1.1 Global Absorbable Drug Eluting Coronary Stent System Sales by Region
- 8.1.2 Global Absorbable Drug Eluting Coronary Stent System Sales Market Share by Region
- 8.2 Global Absorbable Drug Eluting Coronary Stent System Market Size by Region
- 8.2.1 Global Absorbable Drug Eluting Coronary Stent System Market Size by Region
- 8.2.2 Global Absorbable Drug Eluting Coronary Stent System Market Size by Region
- 8.3 North America
- 8.3.1 North America Absorbable Drug Eluting Coronary Stent System Sales by Country
- 8.3.2 North America Absorbable Drug Eluting Coronary Stent System Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Absorbable Drug Eluting Coronary Stent System Sales by Country
- 8.4.2 Europe Absorbable Drug Eluting Coronary Stent System Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Absorbable Drug Eluting Coronary Stent System Sales by Region
- 8.5.2 Asia Pacific Absorbable Drug Eluting Coronary Stent System Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Absorbable Drug Eluting Coronary Stent System Sales by Country
- 8.6.2 South America Absorbable Drug Eluting Coronary Stent System Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Absorbable Drug Eluting Coronary Stent System Sales by Region
- 8.7.2 Middle East and Africa Absorbable Drug Eluting Coronary Stent System Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Absorbable Drug Eluting Coronary Stent System Sales by Region
- 9 Absorbable Drug Eluting Coronary Stent System Market Production by Region
- 9.1 Global Production of Absorbable Drug Eluting Coronary Stent System by Region(2020-2025)
- 9.2 Global Absorbable Drug Eluting Coronary Stent System Revenue Market Share by Region (2020-2025)
- 9.3 Global Absorbable Drug Eluting Coronary Stent System Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Absorbable Drug Eluting Coronary Stent System Production
- 9.4.1 North America Absorbable Drug Eluting Coronary Stent System Production Growth Rate (2020-2025)
- 9.4.2 North America Absorbable Drug Eluting Coronary Stent System Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Absorbable Drug Eluting Coronary Stent System Production
- 9.5.1 Europe Absorbable Drug Eluting Coronary Stent System Production Growth Rate (2020-2025)
- 9.5.2 Europe Absorbable Drug Eluting Coronary Stent System Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Absorbable Drug Eluting Coronary Stent System Production (2020-2025)
- 9.6.1 Japan Absorbable Drug Eluting Coronary Stent System Production Growth Rate (2020-2025)
- 9.6.2 Japan Absorbable Drug Eluting Coronary Stent System Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Absorbable Drug Eluting Coronary Stent System Production (2020-2025)
- 9.7.1 China Absorbable Drug Eluting Coronary Stent System Production Growth Rate (2020-2025)
- 9.7.2 China Absorbable Drug Eluting Coronary Stent System Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Boston Scientific
- 10.1.1 Boston Scientific Basic Information
- 10.1.2 Boston Scientific Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.1.3 Boston Scientific Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.1.4 Boston Scientific Business Overview
- 10.1.5 Boston Scientific SWOT Analysis
- 10.1.6 Boston Scientific Recent Developments
- 10.2 Medtronic
- 10.2.1 Medtronic Basic Information
- 10.2.2 Medtronic Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.2.3 Medtronic Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.2.4 Medtronic Business Overview
- 10.2.5 Medtronic SWOT Analysis
- 10.2.6 Medtronic Recent Developments
- 10.3 Abbott
- 10.3.1 Abbott Basic Information
- 10.3.2 Abbott Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.3.3 Abbott Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.3.4 Abbott Business Overview
- 10.3.5 Abbott SWOT Analysis
- 10.3.6 Abbott Recent Developments
- 10.4 B.Braun
- 10.4.1 B.Braun Basic Information
- 10.4.2 B.Braun Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.4.3 B.Braun Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.4.4 B.Braun Business Overview
- 10.4.5 B.Braun Recent Developments
- 10.5 BD
- 10.5.1 BD Basic Information
- 10.5.2 BD Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.5.3 BD Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.5.4 BD Business Overview
- 10.5.5 BD Recent Developments
- 10.6 Biotronik AG
- 10.6.1 Biotronik AG Basic Information
- 10.6.2 Biotronik AG Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.6.3 Biotronik AG Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.6.4 Biotronik AG Business Overview
- 10.6.5 Biotronik AG Recent Developments
- 10.7 Stentys SA
- 10.7.1 Stentys SA Basic Information
- 10.7.2 Stentys SA Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.7.3 Stentys SA Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.7.4 Stentys SA Business Overview
- 10.7.5 Stentys SA Recent Developments
- 10.8 Sino Medical
- 10.8.1 Sino Medical Basic Information
- 10.8.2 Sino Medical Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.8.3 Sino Medical Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.8.4 Sino Medical Business Overview
- 10.8.5 Sino Medical Recent Developments
- 10.9 Beijing ESSEN Technology
- 10.9.1 Beijing ESSEN Technology Basic Information
- 10.9.2 Beijing ESSEN Technology Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.9.3 Beijing ESSEN Technology Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.9.4 Beijing ESSEN Technology Business Overview
- 10.9.5 Beijing ESSEN Technology Recent Developments
- 10.10 Beijing Advanced Medical Technologies
- 10.10.1 Beijing Advanced Medical Technologies Basic Information
- 10.10.2 Beijing Advanced Medical Technologies Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.10.3 Beijing Advanced Medical Technologies Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.10.4 Beijing Advanced Medical Technologies Business Overview
- 10.10.5 Beijing Advanced Medical Technologies Recent Developments
- 10.11 LifeTech Scientific Corporation
- 10.11.1 LifeTech Scientific Corporation Basic Information
- 10.11.2 LifeTech Scientific Corporation Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.11.3 LifeTech Scientific Corporation Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.11.4 LifeTech Scientific Corporation Business Overview
- 10.11.5 LifeTech Scientific Corporation Recent Developments
- 10.12 MicroPort Scientific Corporation
- 10.12.1 MicroPort Scientific Corporation Basic Information
- 10.12.2 MicroPort Scientific Corporation Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.12.3 MicroPort Scientific Corporation Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.12.4 MicroPort Scientific Corporation Business Overview
- 10.12.5 MicroPort Scientific Corporation Recent Developments
- 10.13 Yilson Medical Technology
- 10.13.1 Yilson Medical Technology Basic Information
- 10.13.2 Yilson Medical Technology Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.13.3 Yilson Medical Technology Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.13.4 Yilson Medical Technology Business Overview
- 10.13.5 Yilson Medical Technology Recent Developments
- 10.14 Lepu Medical Technology
- 10.14.1 Lepu Medical Technology Basic Information
- 10.14.2 Lepu Medical Technology Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.14.3 Lepu Medical Technology Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.14.4 Lepu Medical Technology Business Overview
- 10.14.5 Lepu Medical Technology Recent Developments
- 10.15 Shandong Huaan Biotechnology
- 10.15.1 Shandong Huaan Biotechnology Basic Information
- 10.15.2 Shandong Huaan Biotechnology Absorbable Drug Eluting Coronary Stent System Product Overview
- 10.15.3 Shandong Huaan Biotechnology Absorbable Drug Eluting Coronary Stent System Product Market Performance
- 10.15.4 Shandong Huaan Biotechnology Business Overview
- 10.15.5 Shandong Huaan Biotechnology Recent Developments
- 10.1 Boston Scientific
- 11 Absorbable Drug Eluting Coronary Stent System Market Forecast by Region
- 11.1 Global Absorbable Drug Eluting Coronary Stent System Market Size Forecast
- 11.2 Global Absorbable Drug Eluting Coronary Stent System Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Absorbable Drug Eluting Coronary Stent System Market Size Forecast by Country
- 11.2.3 Asia Pacific Absorbable Drug Eluting Coronary Stent System Market Size Forecast by Region
- 11.2.4 South America Absorbable Drug Eluting Coronary Stent System Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Absorbable Drug Eluting Coronary Stent System by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Absorbable Drug Eluting Coronary Stent System Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Absorbable Drug Eluting Coronary Stent System by Type (2026-2035)
- 12.1.2 Global Absorbable Drug Eluting Coronary Stent System Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Absorbable Drug Eluting Coronary Stent System by Type (2026-2035)
- 12.2 Global Absorbable Drug Eluting Coronary Stent System Market Forecast by Application (2026-2035)
- 12.2.1 Global Absorbable Drug Eluting Coronary Stent System Sales (K Units) Forecast by Application
- 12.2.2 Global Absorbable Drug Eluting Coronary Stent System Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Absorbable Drug Eluting Coronary Stent System Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings